Process for preparation of optically active compounds using transfer hydrogenation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8637713
APP PUB NO 20130096337A1
SERIAL NO

13705884

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A catalytic process for the preparation of optically active compounds and their conversion thereafter to desired drug substances. In particular, the process relates to the preparation of (S)-3-(1-Dimethylamino-ethyl)-phenol using asymmetric catalytic reduction and transfer hydrogenation, thereby providing an improved route to forming drug substances such as rivastigimine and rivastigimine hydrogen tartrate.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS AGLICHTSTRASSE 35 4056 BASEL SWITZERLAND

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Foulkes, Michael Riehen, CH 6 6
Kesselgruber, Martin Basel, CH 7 9
Mathes, Christian Offenburg, DE 10 78

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation